SequelSEC

Scholar Rock Holding Corp SRRK

Biological Products, (No Diagnostic Substances) · CIK 0001727196 · Fiscal year ends 1231

Revenue
$0
Fiscal year ended 2026-06-30
Operating income
-$406.36M
Fiscal year ended 2026-06-30
Free cash flow
-$297.01M
Fiscal year ended 2026-06-30

Scholar Rock Holding Corp (SRRK) reported revenue of $0 and net income of -$408.59M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Scholar Rock Holding Corp’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Biological Products, (No Diagnostic Substances).

Income

Scholar Rock Holding Corp income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$0
Cost of revenueUnavailable
Gross profitUnavailable
Operating income-$406.36M
Net income-$408.59M
Research & development$207.41M
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$198.95M
Selling & marketingUnavailable

Balance

Scholar Rock Holding Corp balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$437.09M
Total assets$523.54M
Current assets$507.18M
Total liabilities$269.76M
Current liabilities$72.24M
Total equity incl. NCI$253.78M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivableUnavailable
GoodwillUnavailable
Long-term debt$196.20M
Accounts payable$11.00M

Cash flow

Scholar Rock Holding Corp cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$296.83M
Capital expenditures$185.00K
Investing cash flow$87.83M
Financing cash flow$494.66M
Net change in cashUnavailable
Stock-based compensation$75.66M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$1.48M

Derived

Scholar Rock Holding Corp derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$297.01M
Gross marginUnavailable
Operating marginUnavailable
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio7.02x
Revenue YoY growthUnavailable
Net marginUnavailable
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equity0.77x
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SRRK in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-03-03View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-14View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.